Form 8-K - Current report:
SEC Accession No. 0001193125-25-053473
Filing Date
2025-03-13
Accepted
2025-03-13 07:07:00
Documents
51
Period of Report
2025-03-13
Items
Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d914751d8k.htm   iXBRL 8-K 27487
2 EX-99.1 d914751dex991.htm EX-99.1 100610
3 EX-99.2 d914751dex992.htm EX-99.2 44124
7 GRAPHIC g914751ex99_2p10g1.jpg GRAPHIC 389850
8 GRAPHIC g914751ex99_2p11g1.jpg GRAPHIC 369555
9 GRAPHIC g914751ex99_2p12g1.jpg GRAPHIC 231508
10 GRAPHIC g914751ex99_2p13g1.jpg GRAPHIC 321070
11 GRAPHIC g914751ex99_2p14g1.jpg GRAPHIC 331405
12 GRAPHIC g914751ex99_2p15g1.jpg GRAPHIC 192850
13 GRAPHIC g914751ex99_2p16g1.jpg GRAPHIC 335581
14 GRAPHIC g914751ex99_2p17g1.jpg GRAPHIC 220227
15 GRAPHIC g914751ex99_2p18g1.jpg GRAPHIC 230473
16 GRAPHIC g914751ex99_2p19g1.jpg GRAPHIC 209596
17 GRAPHIC g914751ex99_2p1g1.jpg GRAPHIC 258073
18 GRAPHIC g914751ex99_2p20g1.jpg GRAPHIC 231302
19 GRAPHIC g914751ex99_2p21g1.jpg GRAPHIC 283657
20 GRAPHIC g914751ex99_2p22g1.jpg GRAPHIC 316364
21 GRAPHIC g914751ex99_2p23g1.jpg GRAPHIC 381939
22 GRAPHIC g914751ex99_2p24g1.jpg GRAPHIC 255326
23 GRAPHIC g914751ex99_2p25g1.jpg GRAPHIC 307561
24 GRAPHIC g914751ex99_2p26g1.jpg GRAPHIC 350517
25 GRAPHIC g914751ex99_2p27g1.jpg GRAPHIC 340491
26 GRAPHIC g914751ex99_2p28g1.jpg GRAPHIC 212070
27 GRAPHIC g914751ex99_2p29g1.jpg GRAPHIC 296122
28 GRAPHIC g914751ex99_2p2g1.jpg GRAPHIC 567133
29 GRAPHIC g914751ex99_2p30g1.jpg GRAPHIC 247183
30 GRAPHIC g914751ex99_2p31g1.jpg GRAPHIC 339676
31 GRAPHIC g914751ex99_2p32g1.jpg GRAPHIC 280825
32 GRAPHIC g914751ex99_2p33g1.jpg GRAPHIC 275343
33 GRAPHIC g914751ex99_2p34g1.jpg GRAPHIC 377995
34 GRAPHIC g914751ex99_2p35g1.jpg GRAPHIC 415352
35 GRAPHIC g914751ex99_2p3g1.jpg GRAPHIC 520926
36 GRAPHIC g914751ex99_2p4g1.jpg GRAPHIC 341182
37 GRAPHIC g914751ex99_2p5g1.jpg GRAPHIC 424033
38 GRAPHIC g914751ex99_2p6g1.jpg GRAPHIC 252269
39 GRAPHIC g914751ex99_2p7g1.jpg GRAPHIC 306368
40 GRAPHIC g914751ex99_2p8g1.jpg GRAPHIC 245518
41 GRAPHIC g914751ex99_2p9g1.jpg GRAPHIC 297721
42 GRAPHIC g914751g0313062016335.jpg GRAPHIC 2666
  Complete submission text file 0001193125-25-053473.txt   15422850

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA mcrb-20250313.xsd EX-101.SCH 2869
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE mcrb-20250313_lab.xml EX-101.LAB 17236
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mcrb-20250313_pre.xml EX-101.PRE 10825
53 EXTRACTED XBRL INSTANCE DOCUMENT d914751d8k_htm.xml XML 3507
Mailing Address 200 SIDNEY STREET CAMBRIDGE MA 02139
Business Address 200 SIDNEY STREET CAMBRIDGE MA 02139 617 945 9626
Seres Therapeutics, Inc. (Filer) CIK: 0001609809 (see all company filings)

EIN.: 274326290 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37465 | Film No.: 25733815
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)